Resolution to issue stock options for directors and employees
First written in FY2016-Q3. 29 of 32 entries say "Advanced", first in FY2017-Q1. Latest entry: 2026-10-02.
106 other companies' latest entry also says "Advanced".
- FY2025AdvancedAnnual report
「Between 1 November 2024 and 31 October 2025, the total number of issued shares increased by 22,500 shares through the exercise of stock acquisition rights.」
The total number of issued shares increased by 22,500 shares through the exercise of stock acquisition rights during the fiscal year. - FY2024-Q1AdvancedAnnual report
「1 November 2023–31 January 2024 24,900」
The total number of issued shares increased by 24,900 shares through the exercise of stock acquisition rights during the first quarter. - FY2023AdvancedAnnual report
「Between 1 November 2022 and 31 October 2023, the total number of issued shares increased by 36,000 shares through the exercise of stock acquisition rights.」
The total number of issued shares increased by 36,000 shares through the exercise of stock acquisition rights during the fiscal year. - FY2023-Q3AdvancedAnnual report
「At a meeting of its Board of Directors held on 11 September 2023, the Company resolved to issue stock acquisition rights to external collaborators pursuant to Articles 236, 238 and 240 of the Companies Act. If all of these stock acquisition rights were exercised, the total number of the Company's common shares would increase by 200,000, resulting in maximum dilution of 0.9%.」
The Company resolved to issue 2,000 stock acquisition rights, representing 200,000 underlying shares, to external collaborators. The exercise period is from 1 October 2023 to 30 September 2028, and maximum dilution of 0.9% is expected. - FY2022AdvancedAnnual report
「Between 1 November 2021 and 31 October 2022, the total number of issued shares increased by 97,050 shares through the exercise of stock acquisition rights.」
The total number of issued shares increased by 97,050 shares through the exercise of stock acquisition rights during the fiscal year. - FY2022-Q3AdvancedAnnual report
「1 May 2022 to 31 July 2022 (Note): 15,975」
During the third quarter, the total number of issued shares increased by 15,975 shares through the exercise of stock acquisition rights. - FY2022-Q2AdvancedAnnual report
「1 February 2022 to 30 April 2022 (Note): 33,075」
The total number of issued shares increased by 33,075 from February to April 2022 as a result of the exercise of share acquisition rights. - FY2022-Q1AdvancedAnnual report
「The total number of issued shares increased by 30,750 during the period from 1 November 2021 to 31 January 2022 as a result of the exercise of share acquisition rights.」
The total number of issued shares increased by 30,750 during the quarter as a result of the exercise of share acquisition rights. - FY2021AdvancedAnnual report
「During the current consolidated fiscal year, the total number of issued shares increased by 24,100 as a result of the exercise of share acquisition rights.」
The total number of issued shares increased by 24,100 as a result of the exercise of share acquisition rights during the fiscal year. The number of shares underlying the share acquisition rights was also adjusted as a result of the share split. - FY2021-Q3AdvancedAnnual report
「The total number of issued shares increased by 9,000 during the period from 1 May 2021 to 31 July 2021 as a result of the exercise of share acquisition rights.」
The total number of issued shares increased by 9,000 during the third-quarter accounting period as a result of the exercise of share acquisition rights. - FY2021-Q2AdvancedAnnual report
「1 February 2021 to 31 March 2021 (Note 1): 4,075; 1 April 2021 to 30 April 2021 (Note 1): 6,750」
The total number of issued shares increased by 10,825 from February to April 2021 as a result of the exercise of share acquisition rights. - FY2021-Q1AdvancedAnnual report
「The total number of issued shares increased by 1,275 during the period from 1 November 2020 to 31 January 2021 as a result of the exercise of share acquisition rights.」
The total number of issued shares increased by 1,275 during the first quarter as a result of the exercise of share acquisition rights. - FY2020AdvancedAnnual report
「The total number of issued shares increased by 59,250 during the period from 1 November 2019 to 31 October 2020 as a result of the exercise of share acquisition rights.」
The total number of issued shares increased by 59,250 as a result of the exercise of share acquisition rights during the fiscal year, up from the previous fiscal year's increase of 36,000. - FY2020-Q3AdvancedAnnual report
「The total number of issued shares increased by 2,000 during the period from 1 May 2020 to 31 July 2020 as a result of the exercise of share acquisition rights.」
The total number of issued shares increased by 2,000 during the third-quarter accounting period as a result of the exercise of share acquisition rights. - FY2020-Q2AdvancedAnnual report
「The total number of issued shares increased by 44,750 during the period from 1 February 2020 to 30 April 2020 as a result of the exercise of share acquisition rights.」
The total number of issued shares increased by 44,750 during the second-quarter accounting period as a result of the exercise of share acquisition rights. - FY2020-Q1AdvancedAnnual report
「The total number of issued shares increased by 6,250 during the period from 1 November 2019 to 31 January 2020 as a result of the exercise of share acquisition rights.」
The total number of issued shares increased by 6,250 during the first quarter as a result of the exercise of share acquisition rights. - FY2019AdvancedAnnual report
「The total number of issued shares increased by 36,000 during the period from 1 November 2018 to 31 October 2019 as a result of the exercise of share acquisition rights.」
The total number of issued shares increased by 36,000 as a result of the exercise of share acquisition rights during the fiscal year. - FY2019-Q3AdvancedAnnual report
「The total number of issued shares increased by 14,000 during the period from 1 May 2019 to 31 July 2019 as a result of the exercise of share acquisition rights.」
The total number of issued shares increased by 14,000 during the third-quarter accounting period as a result of the exercise of share acquisition rights. - FY2019-Q1AdvancedAnnual report
「The total number of issued shares increased by 13,000 during the period from 1 November 2018 to 31 January 2019 as a result of the exercise of share acquisition rights.」
The total number of issued shares increased by 13,000 during the first quarter as a result of the exercise of share acquisition rights. - FY2018AdvancedAnnual report
「The total number of issued shares increased by 34,750 during the period from 1 November 2017 to 31 October 2018 as a result of the exercise of share acquisition rights. In addition, at a meeting of the Board of Directors held on 28 August 2018, the company resolved to issue 40,000 share acquisition rights as stock options to the directors, employees and corporate auditors of the company and its subsidiaries.」
The total number of issued shares increased by 34,750 as a result of the exercise of share acquisition rights during the fiscal year, and a resolution was also passed to issue 40,000 share acquisition rights in the 23rd series. - FY2018-Q3AdvancedAnnual report
「The total number of issued shares increased by 10,500 during the period from 1 May 2018 to 31 July 2018 as a result of the exercise of share acquisition rights. In addition, at a meeting of the Board of Directors held on 28 August 2018, the company resolved to issue 40,000 share acquisition rights as stock options to the directors, employees and corporate auditors of the company and its subsidiaries. 25% of the allocation: period from 1 October 2020 to 28 August 2028; 25% of the allocation: period from 1 October 2021 to 28 August 2028; 25% of the allocation: period from 1 October 2022 to 28 August 2028; 25% of the allocation: period from 1 October 2023 to 28 August 2028.」
The total number of issued shares increased by 10,500 during the third quarter as a result of the exercise of share acquisition rights. In addition, the company resolved to issue 40,000 share acquisition rights in the 23rd series, with staggered exercise periods from 2020 to 2028. - FY2018-Q2AdvancedAnnual report
「The total number of issued shares increased by 4,500 during the period from 1 February 2018 to 30 April 2018 as a result of the exercise of share acquisition rights.」
The total number of issued shares increased by 4,500 during the second quarter as a result of the exercise of share acquisition rights. - FY2018-Q1AdvancedAnnual report
「The total number of issued shares increased by 7,000 during the period from 1 November 2017 to 31 January 2018 as a result of the exercise of share acquisition rights.」
The total number of issued shares increased by 7,000 during the first quarter as a result of the exercise of share acquisition rights. - FY2017AdvancedAnnual report
「The total number of issued shares increased by 40,750 during the period from 1 November 2016 to 31 October 2017 as a result of the exercise of share acquisition rights.」
The total number of issued shares increased by 40,750 as a result of the exercise of share acquisition rights during the fiscal year. In addition, on 28 November 2017, a resolution was passed to issue 2,800 share acquisition rights in the 22nd series to subsidiary directors. - FY2017-Q3AdvancedAnnual report
「The total number of issued shares increased by 4,000 during the period from 1 May 2017 to 31 July 2017 as a result of the exercise of share acquisition rights. At a meeting of the Board of Directors held on 29 August 2017, the company resolved, pursuant to Articles 236, 238 and 240 of the Companies Act, to issue share acquisition rights as stock options to the directors of the company and its subsidiaries, including outside directors, employees and corporate auditors, as set out below. 3. Total number of share acquisition rights: 33,200」
The total number of issued shares increased by 4,000 during the third quarter as a result of the exercise of share acquisition rights. In addition, on 29 August 2017, the company resolved to issue 33,200 share acquisition rights in the 21st series and decided on new grants for officers, employees and others. - FY2017-Q2AdvancedAnnual report
「The total number of issued shares increased by 2,000 during the period from 1 February 2017 to 30 April 2017 as a result of the exercise of share acquisition rights.」
The total number of issued shares increased by 2,000 during the second quarter as a result of the exercise of share acquisition rights. - FY2017-Q1AdvancedAnnual report
「The total number of issued shares increased by 11,250 during the period from 1 November 2016 to 31 January 2017 as a result of the exercise of share acquisition rights.」
The total number of issued shares increased by 11,250 during the period as a result of the exercise of previously issued share acquisition rights. - FY2016RestatedAnnual report
「Total number of share acquisition rights 48,050 25% of the allocation: period from 1 October 2018 to 30 August 2026 25% of the allocation: period from 1 October 2019 to 30 August 2026 25% of the allocation: period from 1 October 2020 to 30 August 2026 25% of the allocation: period from 1 October 2021 to 30 August 2026」
Of the 20th series of share acquisition rights resolved on 30 August 2016, 47,150 remained outstanding, with staggered exercise periods from 2018 to 2026. - FY2016-Q3First statedAnnual report
「At a meeting of the Board of Directors held on 30 August 2016, the Company resolved, pursuant to Articles 236, 238 and 240 of the Companies Act, to issue share options as stock options to directors, including outside directors, and employees of the Company and its subsidiaries, as well as the Company's corporate auditors, as set out below. Total number of share options: 48,050. 25% of the allocation: the period from 1 October 2018 to 30 August 2026. 25% of the allocation: the period from 1 October 2019 to 30 August 2026. 25% of the allocation: the period from 1 October 2020 to 30 August 2026. 25% of the allocation: the period from 1 October 2021 to 30 August 2026.」
The Company resolved to issue 48,050 share options to the relevant directors, employees and other eligible persons, with exercise periods phased from 2018 through 2026.